Recent Finacing
Recent Raise
Mosanna Therapeutics is a clinical-stage biotech developing MOS118, an intranasal small-molecule therapy that targets upper-airway muscles to restore airway reflexes for obstructive sleep apnea, currently in Phase 1.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Mosanna Therapeutics.
